je.st
news
Pricey successor overtakes $1,000-per-pill hepatitis C drug
2015-07-13 10:00:43| Biotech - Topix.net
Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions ... . This image provided by Gilead Sciences shows a bottle of the Hepititis drug Harvoni.
Tags: drug
successor
hepatitis
pricey
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|